• ISRIB (trans-isomer): PERK Inhibitor for ER Stress & Memory

  2026-07-12

  ISRIB (trans-isomer) is establishing a new paradigm in ER stress and cognitive research as a potent PERK inhibitor. This article details advanced experimental workflows, practical troubleshooting, and highlights ISRIB's unique role in preventing memory loss and modulating the integrated stress response. Discover how its mechanism and protocol flexibility can enhance your apoptosis, neurodegeneration, and memory assays.

• PBS (Phosphate-Buffered Saline): Technical Parameters & Lab

  2026-07-10

  PBS (Phosphate-Buffered Saline) addresses the need for a sterile, isotonic buffer solution with physiological pH, crucial for maintaining osmolarity and non-toxicity in cell washing, dilution, and in vitro assay workflows. It is intended solely for laboratory research and is not suitable for diagnostic, clinical, or in vivo applications.

• Sorafenib (BAY-43-9006): Systems Biology Insights for Oncolo

  2026-07-09

  Explore how Sorafenib, a key multikinase inhibitor, is revolutionizing cancer biology research through systems biology and transcriptomics. This article reveals unique protocol strategies and practical insights drawn from recent host-directed antiviral studies.

• Fingolimod (FTY720): Unveiling S1P Modulation for In Vivo T

  2026-07-09

  Explore Fingolimod (FTY720) as a high-affinity S1P modulator and its unique potential for in vivo T cell engineering. This article provides a deep dive into neuroprotection, lymphocyte trafficking, and next-generation immunomodulatory strategies.

• Novobiocin Sodium: Applied Protocols for DNA & Anti-Parasiti

  2026-07-08

  Novobiocin Sodium, a high-purity aminocoumarin antibiotic from APExBIO, empowers researchers to dissect DNA replication, apoptosis, and metabolic enzyme pathways while enabling selective anti-parasitic assays. This guide unpacks practical workflows, troubleshooting tips, and the latest insights on leveraging Novobiocin Sodium for reproducible, high-impact research.

• Mavorixafor Hydrochloride: Precision CXCR4 Antagonism in Gen

  2026-07-08

  Explore how Mavorixafor hydrochloride, a potent CXCR4 antagonist, enables precision research in genomically defined disorders such as Waldenström’s Macroglobulinemia. This article uniquely bridges genetic insight with advanced assay design for translational and anti-HIV applications.

• Topotecan in Recurrent SCLC: Clinical Impact and Innovation

  2026-07-07

  This article reviews the clinical advances and key findings from Ardizzoni's update on Topotecan in recurrent small cell lung cancer (SCLC). The study establishes Topotecan as an effective and tolerable second-line therapy, highlights its mechanism of action, and compares intravenous with oral regimens, providing a benchmark for ongoing translational and experimental cancer research.

• (-)-JQ1: The Gold Standard Inactive Control for BET Inhibiti

  2026-07-07

  (-)-JQ1 is a rigorously validated JQ1 stereoisomer used as a negative control in BET bromodomain inhibition studies. Unlike the active (+)-JQ1, (-)-JQ1 exhibits no significant BRD4 inhibition and is crucial for assay specificity in epigenetics and cancer biology research.

• 2,5-di-tert-butylbenzene-1,4-diol (BHQ) in HSC Mobilization

  2026-07-06

  Explore how 2,5-di-tert-butylbenzene-1,4-diol (BHQ) advances hematopoietic stem cell mobilization by selectively disrupting calcium homeostasis. This in-depth analysis integrates recent mechanistic insights and practical assay guidance for researchers.

• Mapping Allosteric Binding Sites of GCGR for Antagonist Desi

  2026-07-06

  Wang et al. (2024) used a combination of GCGR crystal structures and molecular dynamics simulations to systematically characterize the binding sites of small-molecule antagonists, with a focus on MK 0893. Their findings clarify the structural determinants of antagonist binding and inform the rational design of next-generation glucagon receptor modulators for type 2 diabetes research.

• Ciprofloxacin in Antimicrobial Resistance Models: Protocols

  2026-07-05

  Ciprofloxacin, a research-grade fluoroquinolone antibiotic, is central to advanced studies on bacterial DNA replication inhibition and resistance gene transmission. This guide translates the latest reference findings into actionable protocols and troubleshooting strategies, ensuring robust, reproducible outcomes for antimicrobial resistance research.

• Peroxynitrite, ER Stress, and Necroptosis in Cardiac Microva

  2026-07-04

  Liu et al. (2025) elucidate how peroxynitrite-driven ER stress triggers IP3R-mediated calcium flux to mitochondria, culminating in necroptosis of cardiac microvascular endothelial cells under hyperhomocysteinemia. These findings identify a tractable cell death pathway and suggest new therapeutic targets for mitigating ischemia–reperfusion injury.

• EdU Flow Cytometry Assay Kits (Cy3): Advancing DNA Replicati

  2026-07-03

  The EdU Flow Cytometry Assay Kits (Cy3) from APExBIO revolutionize cell proliferation analysis with denaturation-free, click chemistry–based detection. This article explores experimental workflows, advanced applications in cell cycle and genotoxicity research, and troubleshooting strategies that maximize assay reliability and sensitivity.

• Redefining Immunotherapy: Mechanistic Insights into EZ Cap™

  2026-07-03

  Explore how EZ Cap™ Mouse IL-12 mRNA (m1Ψ) is revolutionizing immunotherapy research by combining advanced mRNA engineering with next-generation delivery platforms. This article provides mechanistic depth and practical guidance beyond existing reviews, with a focus on immune modulation and translational potential.

• Transferring Machine Learning MoA Prediction Across Cell Lin

  2026-07-02

  Warchal et al. rigorously evaluated how well machine learning classifiers predict compound mechanism of action (MoA) when applied across genetically distinct cell lines using high-content imaging data. The study reveals that while convolutional neural networks (CNNs) and ensemble-based tree classifiers perform similarly within a cell line, transferability to novel cell lines remains a challenge, underscoring the complexities of phenotypic profiling for drug discovery.

456 records 12/31 page Previous Next First page 上5页 1112131415 下5页 Last page